Tettero, Jesse M. http://orcid.org/0000-0002-0811-0824
Heidinga, Maaike E.
Mocking, Tim R. http://orcid.org/0000-0001-9170-4131
Fransen, Glenn
Kelder, Angèle
Scholten, Willemijn J.
Snel, Alexander N.
Ngai, Lok Lam http://orcid.org/0000-0003-0969-3766
Bachas, Costa http://orcid.org/0000-0001-5983-6193
van de Loosdrecht, Arjan A. http://orcid.org/0000-0001-8311-983X
Ossenkoppele, Gert J.
de Leeuw, David C.
Cloos, Jacqueline
Janssen, Jeroen J. W. M.
Article History
Received: 24 September 2023
Revised: 8 January 2024
Accepted: 12 January 2024
First Online: 25 January 2024
Competing interests
: GO serves as a consultant for Novartis, Pfizer Inc., Celgene, Janssen, AGIOS, Amgen, Gilead, Astellas, Roche, Jazz Pharmaceuticals and Merus; has received honoraria from Novartis, Celgene, AGIOS, Gilead and Astellas; received research funding from Novartis; and holds a membership on an entity’s Board of Directors for Roche. JC serves as a consultant for Novartis; and has received research funding from Genentech, Novartis and, Merus. JJ serves as a consultant for Bristol-Myers Squibb, Novartis, Pfizer Inc; and has received research funding from Bristol-Myers Squibb, Novartis, Incyte Biosciences Benelux BV, Uppsala County Council, Glycomimetics, Avillion and Ellipses Pharma; and is a Speaker Bureau member for Incyte Biosciences Benelux BV, Roche and Celgene; and holds a membership on an entity’s Board of Directors for Celgene.